3 year average R&D cost to develop new biopharmaceutical compounds 2010-2020
This statistic shows the rolling three-year average cost to research and develop a new biopharmaceutical compound from discovery to launch from 2010 to 2020, by study cohort. In the original study cohort, in the period 2018-2020, the average cost to develop an asset was nearly 2.4 billion U.S. dollars.